Last reviewed · How we verify
EXPAREL 20 mL
EXPAREL 20 mL is a Small molecule drug developed by Pacira Pharmaceuticals, Inc. It is currently FDA-approved. Also known as: bupivacaine liposome injectable suspension.
EXPAREL 20 mL is a formulation of bupivacaine liposome injection used to treat pain in various conditions, including total knee replacement, knee arthroplasty, trauma, and acute pain. It is a type of local anesthetic that works by blocking nerve signals to provide pain relief.
At a glance
| Generic name | EXPAREL 20 mL |
|---|---|
| Also known as | bupivacaine liposome injectable suspension |
| Sponsor | Pacira Pharmaceuticals, Inc |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evaluation of Pain Management After Surgery When Using Exparel in the Pediatric Population (PHASE2)
- Efficacy of EXPAREL vs. Bupivacaine (PHASE3)
- Bupivacaine Liposome Versus Bupivacaine for Ultrasound-Guided Suprascapular Nerve Combined With Axillary Nerve Block in Analgesia After Arthroscopic Shoulder Surgery (PHASE4)
- Liposomal and Standard Bupivacaine in Thoracic Paravertebral Block for Post-Thoracoscopic Pain (PHASE4)
- Effect of Addition of Steroids on Duration of Analgesia (EARLY_PHASE1)
- A Study of Liposomal Bupivacaine Versus 0.25% Bupivacaine Hydrochloride Post Breast Reduction (PHASE4)
- Combination Versus Alone Liposomal Bupivacaine Blocks in Minimally Invasive Thoracic Surgery-1 (NA)
- Pectoralis and Serratus Muscle Blocks (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- EXPAREL 20 mL CI brief — competitive landscape report
- EXPAREL 20 mL updates RSS · CI watch RSS
- Pacira Pharmaceuticals, Inc portfolio CI
Frequently asked questions about EXPAREL 20 mL
What is EXPAREL 20 mL?
Who makes EXPAREL 20 mL?
Is EXPAREL 20 mL also known as anything else?
What development phase is EXPAREL 20 mL in?
Related
- Manufacturer: Pacira Pharmaceuticals, Inc — full pipeline
- Also known as: bupivacaine liposome injectable suspension
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing